Trials / Unknown
UnknownNCT01071187
Varenicline for Alcohol Dependence
Investigation of the Efficacy and Safety of Varenicline in the Postacute Treatment of Alcohol Dependence - a Prospective, Double-blind, Placebo-controlled, Randomised Phase-II Study
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- Sponsor
- Johannes Gutenberg University Mainz · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The varenicline for alcohol dependence trial investigates the efficacy of varenicline versus placebo for maintaining abstinence in the postacute treatment of alcohol dependent subjects. The main study hypothesis is that subjects treated with varenicline have more abstinent days during the study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Varenicline | Varenicline 0,5mg daily on day 1-3, Varenicline 1mg daily on day 4-7 and Varenicline 2mg on day 8-84. |
| DRUG | Placebo | Placebo |
Timeline
- Start date
- 2010-03-01
- Primary completion
- 2011-09-01
- Completion
- 2011-09-01
- First posted
- 2010-02-19
- Last updated
- 2010-09-15
Locations
2 sites across 1 country: Germany
Source: ClinicalTrials.gov record NCT01071187. Inclusion in this directory is not an endorsement.